19 Jul Publications: HIV-NAT
Another publication of HIV-NAT (HIV Netherlands Australia Thailand Research Collaboration) has been accepted
Prevalence of anemia and underlying iron status in naïve antiretroviral therapy HIV-infected children with moderate immune suppression Pope Kosalaraksa, Torsak Bunupuradah, Vonthanak Saphonn, Surapon Wiangnon, Rawiwan Hansudewechakul, Ung Vibol, Suparat Kanchanawanit, Chaiwat Ngampiyaskul, Jurai Wongsawat, Wicharn Luesomboon, Pagakrong Lumbiganon, Bunruan Sopa, Tanakorn Apornpong, Theshinee Chuenyam, David A Cooper AO, Kiat Ruxruthgam, Jintanat Ananworanich, Thanyawee Puthanakit AIDS Research and Human Retroviruses. Jun 2012, ahead of print.
The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT) is affiliated with The Thai Red Cross AIDS Research Centre in Bangkok, Thailand, the Kirby Institute for infection and immunity in society in Sydney, Australia, and the Amsterdam Institute for Global Health and Development. Since 1996 HIV-NAT has been conducting clinical research in HIV, and has grown during the last 14 years into an internationally recognized research organization. The core research areas include pharmacokinetics of HIV therapy, co-infections with Hepatitis B, tuberculosis and HPV, new drug development and cohort and strategic studies. HIV-NAT's co-directors are: Professor Praphan Phanuphak, Professor Joep Lange and Professor David Cooper.